상세 보기
Ribociclib with fulvestrant versus physician's choice treatments in patients who recurred after completion of adjuvant cyclin-dependent kinase 4/6 inhibitors as first-line treatment in HR+, HER2-advanced breast cancer
- Ahn, H.;
- Shin, J.;
- Kim, J.;
- Ahn, J.;
- Park, Y.
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Ribociclib with fulvestrant versus physician's choice treatments in patients who recurred after completion of adjuvant cyclin-dependent kinase 4/6 inhibitors as first-line treatment in HR+, HER2-advanced breast cancer
- 저자
- Ahn, H.; Shin, J.; Kim, J.; Ahn, J.; Park, Y.
- 발행일
- 2026-02-17
- 유형
- Meeting Abstract
- 권
- 32